Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;35(9):e23937.
doi: 10.1002/jcla.23937. Epub 2021 Aug 15.

Analysis of COVID-19 vaccines: Types, thoughts, and application

Xiucui Han  1 , Pengfei Xu  2 , Qing Ye  1
Affiliations
Review

Analysis of COVID-19 vaccines: Types, thoughts, and application

Xiucui Han et al. J Clin Lab Anal. 2021 Sep.

Abstract

Objective: To deal with COVID-19, various countries have made many efforts, including the research and development of vaccines. The purpose of this manuscript was to summarize the development, application, and problems of COVID-19 vaccines.

Methods: This article reviewed the existing literature to see the development of the COVID-19 vaccine.

Results: We found that different types of vaccines had their own advantages and disadvantages. At the same time, the side effects of the vaccine, the dose of vaccination, the evaluation of the efficacy, and the application of the vaccine were all things worth studying.

Conclusion: The successful development of the COVID-19 vaccine concerns almost all countries and people in the world. We must do an excellent job of researching the immunogenicity and immune reactivity of the vaccines. We hope this review can help colleagues at home and abroad.

Keywords: COVID-19; application; thoughts; types; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Shereen MA, Khan S, Kazmi A, et al. COVID‐19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91‐98. - PMC - PubMed
    1. WHO . Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019‐nCoV) [EB/OL]. (2020‐01‐23) [2020‐02‐25]. https://www.who.int/news‐room/detail/23‐01‐2020‐statement‐on‐themeeting‐... committee‐regarding‐the‐outbreak‐of‐novel‐coronavirus‐(2019‐ncov)
    1. Draft landscape of COVID‐19 candidate vaccines; https://www.who.int/publications/m/item/draft‐landscape‐of‐covid‐19‐cand....
    1. Clinical Trials . Draft landscape of COVID‐19 candidate vaccines [EB/OL]. [2020 ‐ 09 ‐ 29]. https: / /www. who. int /publications/m /item /draft‐landscape‐of‐covid‐ 19‐candidate‐vaccines.
    1. Li F, Li W, Farzan M, et al. Structure of SARS coronavirus spike receptor‐binding domain complexed with receptor. Science. 2005;309(5742):1864‐1868. - PubMed

MeSH terms

Substances